Role of Cytokines on the Progression of Liver Fibrosis in Mice Infected with Echinococcus multilocularis

References

• Li T, Ito A, Nakaya K, et al. Species identification of human echinococcosis using histopathology and genotyping in northwestern China. Trans R Soc Trop Med Hyg. 2008;102:585–590. doi:10.1016/j.trstmh.2008.02.01918396303
   PubMed Web of Science ®Google Scholar
• Siles-Lucas M, Casulli A, Cirilli R. Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: compounds and therapeutic targets. PLoS Negl Trop Dis. 2018;12:e0006422. doi:10.1371/journal.pntd.000642229677189
   PubMed Web of Science ®Google Scholar
• Conraths FJ, Probst C, Possenti A, et al. Potential risk factors associated with human alveolar echinococcosis: systematic review and meta-analysis. PLoS Negl Trop Dis. 2017;11:e0005801. doi:10.1371/journal.pntd.000580128715408
   PubMed Web of Science ®Google Scholar
• Jeng KS, Lu SJ, Wang CH, et al. Liver fibrosis and inflammation under the control of ERK2. Int J Mol Sci. 2020;21:3796. doi:10.3390/ijms21113796
   Web of Science ®Google Scholar
• Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27–42. doi:10.1016/j.addr.2017.05.00728506744
   PubMed Web of Science ®Google Scholar
• Xu T, Ni MM, Li X, et al. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis. Int J Biochem Cell Biol. 2016;70:92–104. doi:10.1016/j.biocel.2015.11.01026592197
   PubMed Web of Science ®Google Scholar
• Cui W, Jin HB, Li ZW. Mechanism of the transforming growth factor-beta induction of fibronectin expression in hepatic stem-like cells. Braz J Med Biol Res. 2010;43:36–42. doi:10.1590/S0100-879X200900750001719936542
   PubMed Web of Science ®Google Scholar
• Hsieh CC, Hung CH, Lu L, et al. Hepatic immune tolerance induced by hepatic stellate cells. World J Gastroenterol. 2015;21:11887–11892. doi:10.3748/wjg.v21.i42.1188726576077
   PubMed Web of Science ®Google Scholar
• Medeiros T, Saraiva GN, Moraes LA, et al. Liver fibrosis improvement in chronic hepatitis C after direct acting-antivirals is accompanied by reduced profibrogenic biomarkers-a role for MMP-9/TIMP-1. Dig Liver Dis. 2020;52:1170–1177. doi:10.1016/j.dld.2020.05.00432522433
   PubMedGoogle Scholar
• Khatun M, Ray RB. Mechanisms underlying hepatitis C virus-associated hepatic fibrosis. Cells. 2019;8:1249. doi:10.3390/cells8101249
   PubMed Web of Science ®Google Scholar
• Byun JS, Yi HS. Hepatic immune microenvironment in alcoholic and nonalcoholic liver disease. BioMed Res Int. 2017;2017:1–12. doi:10.1155/2017/6862439
   Web of Science ®Google Scholar
• Hernández-Aquino E, Quezada-Ramírez MA, Silva-Olivares A, et al. Naringenin attenuates the progression of liver fibrosis via inactivation of hepatic stellate cells and profibrogenic pathways. Eur J Pharmacol. 2019;865:172730. doi:10.1016/j.ejphar.2019.17273031618621
   PubMed Web of Science ®Google Scholar
• Shiffman M, Freilich B, Vuppalanchi R, et al. Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2019;49:64–73. doi:10.1111/apt.1503030430605
   PubMed Web of Science ®Google Scholar
• Liang B, Guo XL, Jin J, et al. Glycyrrhizic acid inhibits apoptosis and fibrosis in carbon-tetrachloride-induced rat liver injury. World J Gastroenterol. 2015;21:5271–5280. doi:10.3748/wjg.v21.i17.527125954100
   PubMed Web of Science ®Google Scholar
• Xu R, Zhang Z, Wang FS. Liver fibrosis: mechanisms of immune-mediated liver injury. Cell Mol Immunol. 2012;9:296–301. doi:10.1038/cmi.2011.5322157623
   PubMed Web of Science ®Google Scholar
• Pellicoro A, Ramachandran P, Iredale JP, et al. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol. 2014;14:181–194. doi:10.1038/nri362324566915
   PubMed Web of Science ®Google Scholar
• Zhang C, Shao Y, Yang S, et al. T-cell tolerance and exhaustion in the clearance of Echinococcus multilocularis: role of inoculum size in a quantitative hepatic experimental model [published correction appears in Sci Rep. 2019 Feb 27;9(1):3424]. Sci Rep. 2017;7:11153. doi:10.1038/s41598-017-11703-128894272
   PubMed Web of Science ®Google Scholar
• Choi JS, Jeong IS, Han JH, et al. IL-10-secreting human MSCs generated by TALEN gene editing ameliorate liver fibrosis through enhanced anti-fibrotic activity. Biomater Sci. 2019;7:1078–1087. doi:10.1039/c8bm01347k30631870
   PubMed Web of Science ®Google Scholar
• Karabulut D, Akin AT, Unsal M, et al. L-Carnitine ameliorates the liver by regulating alpha-SMA, iNOS, HSP90, HIF-1alpha, and RIP1 expressions of CCL4-toxic rats. Iran J Basic Med Sci. 2021;24:184–190. doi:10.22038/IJBMS.2020.47711.1099033953857
   PubMed Web of Science ®Google Scholar
• Choi JS, Jeong IS, Park YJ, et al. HGF and IL-10 expressing ALB:: GFPreporter cells generated from iPSCs show robust anti-fibrotic property in acute fibrotic liver model. Stem Cell Res Ther. 2020;11:332. doi:10.1186/s13287-020-01745-032746905
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang J, Lü G, et al. Hepatocyte proliferation/growth arrest balance in the liver of mice during E. multilocularis infection: a coordinated 3-stage course. PLoS One. 2012;7(1):e30127. doi:10.1371/journal.pone.003012722253905
   PubMed Web of Science ®Google Scholar
• Tian F, Liu Y, Gao J, et al. Study on the association between TGF-β1 and liver fibrosis in patients with hepatic cystic echinococcosis. Exp Ther Med. 2020;19:1275–1280. doi:10.3892/etm.2019.835532010299
   PubMed Web of Science ®Google Scholar
• Modol T, Brice N, Ruiz de Galarreta M, et al. Fibronectin peptides as potential regulators of hepatic fibrosis through apoptosis of hepatic stellate cells. J Cell Physiol. 2015;230:546‑53. doi:10.1002/jcp.24714
   Web of Science ®Google Scholar
• Dayer C, Stamenkovic I. Recruitment of matrix metal- loproteinase‑9 (MMP‑9) to the fibroblast cell surface by lysyl hydroxylase 3 (LH3) triggers transforming growth factor‑β(TGF-β) activation and fibroblast differentiation. J Biol Chem. 2015;290:13763‑78. doi:10.1074/jbc.M114.622274
   Web of Science ®Google Scholar
• Atta H, El‑Rehany M, Hammam O, et al. Mutant MMP‑9 and HGF gene transfer enhance resolution of CCl4‑induced liver fibrosis in rats: role of ASH1 and EZH2 methyltransferases repression. PLoS One. 2014;9:e112384. doi:10.1371/journal.pone.011238425380300
   PubMed Web of Science ®Google Scholar
• Koyama Y, Brenner DA. Liver inflammation and fibrosis. J Clin Invest. 2017;127:55–64. doi:10.1172/JCI8888128045404
   PubMed Web of Science ®Google Scholar
• Li X, Yao X, Zhu Y, et al. The caspase inhibitor Z-VAD-FMK alleviates endotoxic shock via inducing macrophages necroptosis and promoting MDSCs mediated inhibition of macrophages activation. Front Immunol. 2019;10:1824. doi:10.3389/fimmu.2019.0182431428103
   PubMed Web of Science ®Google Scholar
• Kearney CJ, Martin SJ. An inflammatory perspective on necroptosis. Mol Cell. 2017;65:965–973. doi:10.1016/j.molcel.2017.02.02428306512
   PubMed Web of Science ®Google Scholar